Draxxin® Injectable Solution

(tulathromycin)

USES:

Treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Pinkeye – Draxxin Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis. Foot rot – Draxxin Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.

Expand All

KEY BENEFITS
Highly effective against the for major BRD bacteria Pathogens – Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis.

Only cattle antimicrobial approved by the FDA for both the treatment and control of BRD associated with Mycoplasma bovis.

Convenient, full course of therapy in a single dose.

Only cattle antimicrobial that has consistently demonstrated superior first treatment results when compared to Baytril®, Nuflor® and Micotil® in field BRD trials

Rapid release + absorption from the injection site.

Extensive distribution.

Slow elimination.

High, prolonged lung tissue concentration.

PRESENTATION

50 mL, 100 mL, 250 mL and 500 mL vials.

DOSING AND ADMINSTRATION

1 ml/ 40 kg Body Weight Subcutaneous

IMPORTANT SAFETY INFORMATION
Do not use in female dairy cattle 20 months of age or older.

Do not use in calves to be processed for veal.

18 day pre-slaughter withdrawal.

You are leaving the country website to access another site in the group.

Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.